Skip to main content

Precision Medicine Spend to Reach $132.3 Billion

Precision Medicine uses molecular info to extract the optimum medical method from diagnostic protocols, by merging the impact of environmental and genetic factors. Data access is essential, with genetic metabolic and clinical data used to build a fuller picture of a patient's biology.

Moreover, the primary aim of precision medicine is to design and optimize a pathway for diagnosis, therapeutic intervention, and prognosis, using large biological datasets.

Personalized, evidence-based medicine uses stored health data, which includes patient diagnosis, laboratory work, insurance claims, and demographic information. The results enable healthcare providers to predict and prevent some illnesses.

Precision Medicine Market Development

According to the latest worldwide market study by Juniper Research, the total investment in precision medicine will reach $132.3 billion globally by 2027 -- that's increasing from only $35.7 billion in 2022.

The significant market growth of 270 percent is a result of emerging technologies and infrastructure -- such as artificial intelligence (AI) -- which aids precision medicine by predicting risks for certain diseases.

These technological advancements, combined with the healthcare sector’s need to increase efficiencies in the face of a potential economic downturn, will encourage healthcare providers to invest further in precision medicine.

According to the Juniper assessment, precision medicine leverages advances in personal genomics to enable healthcare providers to prepare preventative plans and disease treatments based on gene variability.

Reductions in adverse reactions from ineffective medication, improving the efficacy of treatment plans via personalization, and cutting patient spending on medication, will be the primary drivers of precision medicine adoption among healthcare providers.

To maximize these medical benefits, Juniper analysts identified the use of AI to ingest and process large amounts of healthcare data to increase the future accuracy of medical diagnoses.

"The rapid increase in accuracy, as systems become more advanced, will create a virtuous cycle of continuous improvement; catalyzing further growth and adoption of precision medicine in healthcare sectors over the next 5 years," said Cara Malone, research analyst at Juniper Research.

The latest research finding identified that the most significant public policy issue surrounding precision medicine will likely arise from patient data privacy concerns. In particular, if and when a person's genetic data is stored and shared without permission.

In many countries, but predominantly in the U.S. market, there is suspicion that uncovering genetic predispositions using precision medicine could lead to medical insurance providers leveraging these insights to increase healthcare premiums.

Outlook for Regional Growth of Precision Medicine

To allay these concerns, all medical technology vendors must consider voluntarily adopting strong codes of conduct around data privacy, as well as creating independent advisory councils, to reassure people and limit the scope of data sharing.

That said, I believe personal genetic data privacy will become of paramount importance across the globe, as more national and international government bodies create medical data governance policies that regulate this emerging sector of the Global Networked Economy.

Popular posts from this blog

Global Rise of Domestic Payment Ecosystems

Alternative Payment Methods (APMs) – comprising digital wallets, instant payments, and QR payment systems – are experiencing explosive growth that's reshaping the global financial services marketplace. According to the latest worldwide market study by ABI Research , the combined global transaction value for APMs is projected to reach $142 trillion by 2030. What's particularly fascinating is the underlying driver behind this trend: a growing desire for financial sovereignty, with nations developing domestic payment ecosystems rather than remaining dependent on international financial networks. Payment Ecosystem Market Development In 2024, approximately 45 percent of the global population used digital wallets – a remarkable adoption rate for a technology that barely existed a decade ago. China leads this transition, with 95 percent of its population using WeChat's payment functionality. WeChat exemplifies the "super app" phenomenon, where payment capabilities are in...